Morgan Stanley’s ETRACS Alerian MLP Index ETN Series B due July 18 2042 AMUB Stock Holding History
Bought
Maintained
Sold
Other funds holding AMUB
NC
VF
HW
PTC
Morgan Stanley's AMUB Position: Q1 2026 in Review
Morgan Stanley reduced its ETRACS Alerian MLP Index ETN Series B due July 18 2042 (AMUB) stake by 74% in Q1 2026, selling an estimated $91.1K and leaving 1,508 shares worth $32.7K. The position accounts for ﹤0.01% of the portfolio, ranked #6562.
Morgan Stanley first reported a position in AMUB in Q1 2020 and has held it in 25 quarters since. The position peaked at $258K in Q4 2023. 7 funds tracked by Wall St. Rank hold AMUB as of Q1 2026.
- Morgan Stanley held 1,508 shares of ETRACS Alerian MLP Index ETN Series B due July 18 2042 worth $32.7K as of Q1 2026.
- Morgan Stanley sold 4,356 ETRACS Alerian MLP Index ETN Series B due July 18 2042 shares in Q1 2026, an estimated $91.1K.
- ETRACS Alerian MLP Index ETN Series B due July 18 2042 made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #6562 holding.
- Morgan Stanley first reported a position in ETRACS Alerian MLP Index ETN Series B due July 18 2042 in Q1 2020 and has held it in 25 quarters since.
- Morgan Stanley's ETRACS Alerian MLP Index ETN Series B due July 18 2042 position peaked at $258K in Q4 2023.
- 7 funds tracked by Wall St. Rank held ETRACS Alerian MLP Index ETN Series B due July 18 2042 as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.